Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombosis;Portal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04850157
What this trial is testing

Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 30
Not applicableNot Yet RecruitingNCT06772298
What this trial is testing

Study of Oxidized Albumin in Liver Transplant Patients

Who this might be right for
Liver FailureLiver CirrhosisLiver Transplant Disorder
Region Stockholm 10
Post-approval studies (Phase 4)Study completedNCT04173429
What this trial is testing

Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis

Who this might be right for
Liver CirrhosisPortal Vein Thrombosis
Qilu Hospital of Shandong University 64
Large-scale testing (Phase 3)UnknownNCT03939845
What this trial is testing

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 180
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Post-approval studies (Phase 4)Study completedNCT00646100
What this trial is testing

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 164
Not applicableStudy completedNCT05535998
What this trial is testing

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma
Yunfei Yuan 743
Not applicableNot Yet RecruitingNCT07108023
What this trial is testing

Hematological Disorders in EHPVO Patients

Who this might be right for
Extrahepatic Portal Vein Obstruction (EHPVO)ThrombophiliaMyeloproliferative Neoplasms (MPN)+5 more
Rahab Nady 115
Not applicableUnknownNCT06054451
What this trial is testing

Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India

Who this might be right for
Portal HypertensionBudd-Chiari SyndromeNon-Cirrhotic Portal Hypertension+4 more
Post Graduate Institute of Medical Education and Research, Chandigarh 210
Not applicableUnknownNCT04433481
What this trial is testing

Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis

Who this might be right for
Liver CirrhosisPortal Vein Thrombosis
Institute of Liver and Biliary Sciences, India 84
Not applicableUnknownNCT03730675
What this trial is testing

Irradiation Stent Placement Plus TACE for HCC and PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Zhongda Hospital 308
Large-scale testing (Phase 3)Study completedNCT02555111
What this trial is testing

Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.

Who this might be right for
Deep Vein ThrombosisChronic Portal Vein Thrombosis
Assistance Publique - Hôpitaux de Paris 112
Large-scale testing (Phase 3)UnknownNCT04387695
What this trial is testing

SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT

Who this might be right for
Unresectable Hepatocellular CarcinomaPortal Vein Thrombosis
First Affiliated Hospital of Zhejiang University 54
Testing effectiveness (Phase 2)Study completedNCT00849264
What this trial is testing

Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Eastern Hepatobiliary Surgery Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT03035006
What this trial is testing

Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Tumor Thrombosis
Taiwan Liposome Company 1
Not applicableLooking for participantsNCT06624098
What this trial is testing

Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaVariceal Bleeding
Sun Yat-sen University 22
Not applicableStudy completedNCT05040347
What this trial is testing

Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular Carcinoma

Who this might be right for
Neutrophil Extracellular Trap FormationPortal Vein Tumor Thrombosis
The Affiliated Hospital of Qingdao University 68
Large-scale testing (Phase 3)Ended earlyNCT01887717
What this trial is testing

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 36
Large-scale testing (Phase 3)UnknownNCT02971345
What this trial is testing

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 253
Not applicableLooking for participantsNCT07799922
What this trial is testing

IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus

Who this might be right for
IRE
Tianjin Medical University Cancer Institute and Hospital 60
Next Page